Skip to main content
Top
Published in: Journal of Clinical Immunology 2/2012

01-04-2012

Characterizing the Pregnancy Immune Phenotype: Results of the Viral Immunity and Pregnancy (VIP) Study

Authors: Thomas A. Kraus, Stephanie M. Engel, Rhoda S. Sperling, Lisa Kellerman, Yungtai Lo, Sylvan Wallenstein, Maria M. Escribese, Jose L. Garrido, Tricia Singh, Martine Loubeau, Thomas M. Moran

Published in: Journal of Clinical Immunology | Issue 2/2012

Login to get access

Abstract

Purpose

The increased risk of morbidity and mortality from certain microbial infections and the demonstrated improvements in the clinical course of some autoimmune diseases support the existence of pregnancy-related alterations in immune status. Elucidating the changes in innate and adaptive immunity during gestation may improve pregnancy outcomes and facilitate the development of targeted therapies for autoimmune diseases.

Method

The Viral Immunity and Pregnancy (VIP) study evaluated over 50 subjects longitudinally at three time points during pregnancy and at two time points post-delivery. Leukocyte enumeration was performed; functional responses of NK cells and CD4 T cells were analyzed, and soluble factors such as cytokines, defensins, and steroid hormones were measured in maternal blood.

Results

In comparison to the post-partum period, the latter part of pregnancy was characterized by significant increases in blood phagocytes and pDCs and decreases in the number and activity of NK and T cells. Alterations were found in antimicrobial proteins and serum cytokines.

Conclusions

These data show that pregnancy is not a period of immunosuppression but an alteration in immune priorities characterized by a strengthening of innate immune barriers and a concomitant reduction in adaptive/inflammatory immunity in the later stages of pregnancy.
Literature
2.
go back to reference Stockman LJ, et al. SARS during pregnancy, United States. Emerg Infect Dis. 2004;10(9):1689–90.PubMed Stockman LJ, et al. SARS during pregnancy, United States. Emerg Infect Dis. 2004;10(9):1689–90.PubMed
3.
go back to reference Harger JH, et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis. 2002;185(4):422–7.PubMedCrossRef Harger JH, et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis. 2002;185(4):422–7.PubMedCrossRef
5.
go back to reference Shulman CE, Dorman EK. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg. 2003;97(1):30–5.PubMedCrossRef Shulman CE, Dorman EK. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg. 2003;97(1):30–5.PubMedCrossRef
6.
go back to reference Harris J. Influenza occurring in pregnant women. Journal of the American Medical Association, 1919;72:978–980. Harris J. Influenza occurring in pregnant women. Journal of the American Medical Association, 1919;72:978–980.
7.
go back to reference Greenberg M, et al. Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol. 1958;76(4):897–902.PubMed Greenberg M, et al. Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol. 1958;76(4):897–902.PubMed
8.
go back to reference Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol. 1959;78:1172–5.PubMed Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol. 1959;78:1172–5.PubMed
9.
go back to reference Neuzil KM, et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998;148(11):1094–102.PubMed Neuzil KM, et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998;148(11):1094–102.PubMed
10.
go back to reference Klein SL, et al. The impact of sex, gender and pregnancy on 2009 H1N1 disease. Biol Sex Differ. 2010;1(1):5.PubMedCrossRef Klein SL, et al. The impact of sex, gender and pregnancy on 2009 H1N1 disease. Biol Sex Differ. 2010;1(1):5.PubMedCrossRef
11.
go back to reference Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis. 2008;14(1):95–100.PubMedCrossRef Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis. 2008;14(1):95–100.PubMedCrossRef
12.
go back to reference Siston AM, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303(15):1517–25.PubMedCrossRef Siston AM, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303(15):1517–25.PubMedCrossRef
13.
go back to reference Reid A. The effects of the 1918–1919 influenza pandemic on infant and child health in Derbyshire. Med Hist. 2005;49(1):29–54.PubMed Reid A. The effects of the 1918–1919 influenza pandemic on infant and child health in Derbyshire. Med Hist. 2005;49(1):29–54.PubMed
14.
go back to reference Beigi RH. Pandemic influenza and pregnancy: a call for preparedness planning. Obstet Gynecol. 2007;109(5):1193–6.PubMedCrossRef Beigi RH. Pandemic influenza and pregnancy: a call for preparedness planning. Obstet Gynecol. 2007;109(5):1193–6.PubMedCrossRef
15.
go back to reference Irving WL, et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG. 2000;107(10):1282–9.PubMedCrossRef Irving WL, et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG. 2000;107(10):1282–9.PubMedCrossRef
16.
go back to reference Billington WD. The immunological problem of pregnancy: 50 years with the hope of progress. A tribute to Peter Medawar. J Reprod Immunol. 2003;60(1):1–11.PubMedCrossRef Billington WD. The immunological problem of pregnancy: 50 years with the hope of progress. A tribute to Peter Medawar. J Reprod Immunol. 2003;60(1):1–11.PubMedCrossRef
17.
go back to reference Wegmann TG, et al. Bidirectional cytokine interactions in the maternal–fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today. 1993;14(7):353–6.PubMedCrossRef Wegmann TG, et al. Bidirectional cytokine interactions in the maternal–fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today. 1993;14(7):353–6.PubMedCrossRef
18.
go back to reference Chaouat G. The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol. 2007;29(2):95–113.PubMedCrossRef Chaouat G. The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol. 2007;29(2):95–113.PubMedCrossRef
19.
go back to reference Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy—an inflammatory view. Trends Immunol. 2006;27(9):399–404.PubMedCrossRef Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy—an inflammatory view. Trends Immunol. 2006;27(9):399–404.PubMedCrossRef
20.
go back to reference Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010;63(6):425–33.PubMedCrossRef Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010;63(6):425–33.PubMedCrossRef
21.
go back to reference Lin H, et al. Synthesis of T helper 2-type cytokines at the maternal–fetal interface. J Immunol. 1993;151(9):4562–73.PubMed Lin H, et al. Synthesis of T helper 2-type cytokines at the maternal–fetal interface. J Immunol. 1993;151(9):4562–73.PubMed
22.
go back to reference Sacks GP, Redman CW, Sargent IL. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol. 2003;131(3):490–7.PubMedCrossRef Sacks GP, Redman CW, Sargent IL. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol. 2003;131(3):490–7.PubMedCrossRef
23.
go back to reference Kraus TA, et al. Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol. 2010;64(6):411–26.PubMedCrossRef Kraus TA, et al. Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol. 2010;64(6):411–26.PubMedCrossRef
24.
25.
go back to reference Rodriguez-Garcia M, et al. Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3. J Leukoc Biol. 2007;82(5):1143–6.PubMedCrossRef Rodriguez-Garcia M, et al. Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3. J Leukoc Biol. 2007;82(5):1143–6.PubMedCrossRef
26.
go back to reference Escribese, M., et al., Alpha-defensins 1-3 release by dendritic cells is reduced by estrogen Reproductive Biology and Endocrinology, 2011 (in press) Escribese, M., et al., Alpha-defensins 1-3 release by dendritic cells is reduced by estrogen Reproductive Biology and Endocrinology, 2011 (in press)
27.
go back to reference Medina KL, Smithson G, Kincade PW. Suppression of B lymphopoiesis during normal pregnancy. J Exp Med. 1993;178(5):1507–15.PubMedCrossRef Medina KL, Smithson G, Kincade PW. Suppression of B lymphopoiesis during normal pregnancy. J Exp Med. 1993;178(5):1507–15.PubMedCrossRef
28.
go back to reference Kincade PW, et al. Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev. 2000;175:128–37.PubMedCrossRef Kincade PW, et al. Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev. 2000;175:128–37.PubMedCrossRef
29.
go back to reference Matthiesen L, et al. Lymphocyte subsets and autoantibodies in pregnancies complicated by placental disorders. Am J Reprod Immunol. 1995;33(1):31–9.PubMed Matthiesen L, et al. Lymphocyte subsets and autoantibodies in pregnancies complicated by placental disorders. Am J Reprod Immunol. 1995;33(1):31–9.PubMed
30.
go back to reference Fiddes TM, et al. Phenotypic and functional evaluation of suppressor cells in normal pregnancy and in chronic aborters. Cell Immunol. 1986;97(2):407–18.PubMedCrossRef Fiddes TM, et al. Phenotypic and functional evaluation of suppressor cells in normal pregnancy and in chronic aborters. Cell Immunol. 1986;97(2):407–18.PubMedCrossRef
31.
go back to reference Luppi P, et al. Normal pregnancy is associated with peripheral leukocyte activation. Am J Reprod Immunol. 2002;47(2):72–81.PubMedCrossRef Luppi P, et al. Normal pregnancy is associated with peripheral leukocyte activation. Am J Reprod Immunol. 2002;47(2):72–81.PubMedCrossRef
32.
go back to reference Kuhnert M, et al. Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 1998;76(2):147–51.PubMedCrossRef Kuhnert M, et al. Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 1998;76(2):147–51.PubMedCrossRef
33.
go back to reference Sabahi F, et al. Qualitative and quantitative analysis of T lymphocytes during normal human pregnancy. Am J Reprod Immunol. 1995;33(5):381–93.PubMed Sabahi F, et al. Qualitative and quantitative analysis of T lymphocytes during normal human pregnancy. Am J Reprod Immunol. 1995;33(5):381–93.PubMed
34.
go back to reference Praloran V, et al. Elevation of serum M-CSF concentrations during pregnancy and ovarian hyperstimulation. Br J Haematol. 1994;86(3):675–7.PubMedCrossRef Praloran V, et al. Elevation of serum M-CSF concentrations during pregnancy and ovarian hyperstimulation. Br J Haematol. 1994;86(3):675–7.PubMedCrossRef
35.
go back to reference Shibuya T, et al. Study on nonspecific immunity in pregnant women: increased chemiluminescence response of peripheral blood phagocytes. Am J Reprod Immunol Microbiol. 1987;15(1):19–23.PubMed Shibuya T, et al. Study on nonspecific immunity in pregnant women: increased chemiluminescence response of peripheral blood phagocytes. Am J Reprod Immunol Microbiol. 1987;15(1):19–23.PubMed
36.
go back to reference Hanna J, et al. Decidual NK cells regulate key developmental processes at the human fetal–maternal interface. Nat Med. 2006;12(9):1065–74.PubMedCrossRef Hanna J, et al. Decidual NK cells regulate key developmental processes at the human fetal–maternal interface. Nat Med. 2006;12(9):1065–74.PubMedCrossRef
37.
go back to reference Burke SD, et al. Uterine NK cells, spiral artery modification and the regulation of blood pressure during mouse pregnancy. Am J Reprod Immunol. 2010;63(6):472–81.PubMedCrossRef Burke SD, et al. Uterine NK cells, spiral artery modification and the regulation of blood pressure during mouse pregnancy. Am J Reprod Immunol. 2010;63(6):472–81.PubMedCrossRef
38.
go back to reference Delgado SR, et al. Accounting for the peripartum loss of granulated metrial gland cells, a natural killer cell population, from the pregnant mouse uterus. J Leukoc Biol. 1996;59(2):262–9.PubMed Delgado SR, et al. Accounting for the peripartum loss of granulated metrial gland cells, a natural killer cell population, from the pregnant mouse uterus. J Leukoc Biol. 1996;59(2):262–9.PubMed
39.
go back to reference Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol. 1999;103(2 Pt 1):282–8.PubMedCrossRef Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol. 1999;103(2 Pt 1):282–8.PubMedCrossRef
40.
go back to reference Grimaldi CM, Michael DJ, Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol. 2001;167(4):1886–90.PubMed Grimaldi CM, Michael DJ, Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol. 2001;167(4):1886–90.PubMed
41.
go back to reference Wrammert J, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med. 2011;208(1):181–93.PubMedCrossRef Wrammert J, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med. 2011;208(1):181–93.PubMedCrossRef
Metadata
Title
Characterizing the Pregnancy Immune Phenotype: Results of the Viral Immunity and Pregnancy (VIP) Study
Authors
Thomas A. Kraus
Stephanie M. Engel
Rhoda S. Sperling
Lisa Kellerman
Yungtai Lo
Sylvan Wallenstein
Maria M. Escribese
Jose L. Garrido
Tricia Singh
Martine Loubeau
Thomas M. Moran
Publication date
01-04-2012
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 2/2012
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-011-9627-2

Other articles of this Issue 2/2012

Journal of Clinical Immunology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.